Difference between revisions of "EIBIR/QIBA ASL Biomarker Ctte"
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
<br />Note: Meeting summaries are posted after they are approved by the ASL BC during the following t-con | <br />Note: Meeting summaries are posted after they are approved by the ASL BC during the following t-con | ||
| + | *[[Media:2023_10-11_EIBIR-QIBA_ASL_Meeting_Summary.pdf|October 11, 2023]] | ||
*[[Media:2023_02-24_EIBALL-QIBA_ASL_BC_Meeting_Summary-FINAL.pdf|February 24, 2023]] | *[[Media:2023_02-24_EIBALL-QIBA_ASL_BC_Meeting_Summary-FINAL.pdf|February 24, 2023]] | ||
*[[Media:2022_06-30_EIBIR-QIBA_ASL_BC_Meeting_Summary-FINAL.pdf|June 30, 2022]] | *[[Media:2022_06-30_EIBIR-QIBA_ASL_BC_Meeting_Summary-FINAL.pdf|June 30, 2022]] | ||
| − | |||
'''''[[ASL Meeting Summaries Archive]]''''' | '''''[[ASL Meeting Summaries Archive]]''''' | ||
Revision as of 14:44, 9 November 2023
- Co-chairs: Xavier Golay, PhD; Karl-Olof Lovblad, MD; Patricia Clement, PhD
- Staff Support provided by EIBIR
Project Snapshot
Develop a quantitative imaging profile for Arterial Spin Labeling imaging.
This effort is supported by EIBIR, using the QIBA Process for Profile development.
ASL BC Meetings
Recent approved meeting summaries:
Note: Meeting summaries are posted after they are approved by the ASL BC during the following t-con
Profile Development
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee File:To be added.pdf